BSX Filing
4Filing Date: Aug 7, 2026

BOSTON SCIENTIFIC CORP (BSX) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001225208-26-007031open_in_new
Total Value$99.9K
Trades1
Insiders1

Transaction Details

Habiger David C
Director·Direct
Buy · Acquire
Common Stock
Shares+2.10K
Price$47.59
Total Value$99.9K
Shares Owned After17.16K
Transaction DateAug 5, 2026
Footnotes ▸

Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $47.21 to $47.98, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Post-Transaction Holdings

Habiger David C
SecuritySharesChange
Common Stock17.16K+2.10K (13.94%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-08-05 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: BOSTON SCIENTIFIC CORP (BSX) CIK: 0000885725 --- Reporting Owner --- Name: Habiger David C CIK: 0001326409 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-08-05 | Code: P (Open market purchase) Shares: +2,100 | Price: $47.59 Total Value: $99,936.90 Shares Owned After: 17,160 | Ownership: D (Direct) Footnotes: [F1] Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $47.21 to $47.98, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. --- Footnotes (Complete Index) --- F1: Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $47.21 to $47.98, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. --- Signature --- /s/ /s/ Susan Thompson, Attorney-in-Fact (2026-08-07)

keid analysis is for reference only and does not constitute investment advice.